Shea Thomas B., Ekinci Fatma J.
Center for Cellular Neurobiology and Neurodegeneration Research, Department of Biological Sciences, University of Massachusetts at Lowell, Lowell, USA.
J Alzheimers Dis. 1999 Dec;1(6):353-360. doi: 10.3233/jad-1999-1601.
Conflicting data has emerged documenting decreased and increased levels of phospho-tau following calcium influx. Calcium influx achieved by treatment of SH-SY-5Y human neuroblastoma with 1 micro M calcium ionophore A23187 in the presence of 0.1 mM extracellular calcium depleted phospho-tau levels within 30 min. However, extending ionophore treatment to 60 min raised phospho-tau levels beyond that of control levels. Total tau levels were unchanged throughout these treatments, indicating that the reduction in PHF-1 reflected sequential alterations in tau phosphorylation rather than total tau. More rapid accumulation of phospho-tau accompanied treatment with increased concentrations of ionophore (3 micro M) and extracellular calcium (0.9 mM). An inhibitor active against calcium-dependent kinase(s) prevented the increase in phospho-tau following calcium influx. These data underscore that phospho-tau levels represent the summation of kinase and phosphatase activities and indicate that net dephosphorylation or phosphorylation is dependent upon the extent and/or rate of calcium influx
出现了相互矛盾的数据,记录了钙内流后磷酸化tau水平的降低和升高。在用1微摩尔钙离子载体A23187处理SH-SY-5Y人神经母细胞瘤并存在0.1毫摩尔细胞外钙的情况下实现的钙内流,在30分钟内使磷酸化tau水平降低。然而,将离子载体处理延长至60分钟会使磷酸化tau水平升高超过对照水平。在这些处理过程中总tau水平没有变化,表明PHF-1的降低反映了tau磷酸化的顺序改变而非总tau。随着离子载体浓度增加(3微摩尔)和细胞外钙增加(0.9毫摩尔),磷酸化tau的积累更快。一种对钙依赖性激酶有活性的抑制剂可阻止钙内流后磷酸化tau的增加。这些数据强调磷酸化tau水平代表激酶和磷酸酶活性的总和,并表明净去磷酸化或磷酸化取决于钙内流的程度和/或速率